• Home
  • Search Results
  • In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.

In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.

Toxicology letters (2014-12-03)
Seung Jun Lee, Jung Bae Park, Doyun Kim, Soo Hyeon Bae, Young-Won Chin, Euichaul Oh, Soo Kyung Bae
ABSTRACT

In the present study, we evaluated the inhibitory potentials of finasteride for the major human hepatic UDP-glucuronosyltransferases (UGTs) (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, UGT2B7, and UGT2B15) in vitro using LC-MS/MS by specific marker reactions in human liver microsomes (except for UGT2B15) or recombinant supersomes (UGT2B15). Of the seven tested UGTs, finasteride potently, selectively, and competitively inhibited UGT1A4-mediated trifluoperazine-N-glucuronidation in human liver microsomes with an IC₅₀ value of 11.5 ± 1.78 μM and Ki value of 6.03 ± 0.291 μM. This inhibitory potency was similar to that of hecogenin, a well-known inhibitor of UGT1A4. However, finasteride did not seem to inhibit any of the other six UGTs: UGT1A1, UGT1A3, UGT1A6, UGT1A9, UGT2B7, or UGT2B15. Similarly, finasteride markedly inhibited UGT1A4 activity in recombinant human UGT1A4 supersomes, with a Ki value of 6.05 ± 0.410 μM. In addition, finasteride strongly inhibited UGT1A4-catalyzed imipramine-N-β-D-glucuronidation. However, on the basis of an in vitro-in vivo extrapolation, our data strongly suggested that finasteride is unlikely to cause clinically significant drug-drug interactions mediated via inhibition of the hepatic UGT enzymes involved in drug metabolism in vivo.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Serotonin hydrochloride, powder
Sigma-Aldrich
4-Methylumbelliferone, ≥98%
Sigma-Aldrich
1-Naphthol, ReagentPlus®, ≥99%
Sigma-Aldrich
Theophylline, anhydrous, ≥99%, powder
Sigma-Aldrich
Uridine, ≥99%
Sigma-Aldrich
Uridine, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Chenodeoxycholic acid
Sigma-Aldrich
Finasteride, ≥98% (HPLC), powder
Supelco
Theophylline, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
2,6-Diisopropylphenol, 97%
Sigma-Aldrich
3′-Azido-3′-deoxythymidine, ≥98% (HPLC)
Supelco
Zidovudine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Uridine, BioUltra, ≥99%
Sigma-Aldrich
Niflumic acid
Sigma-Aldrich
1-Naphthol, puriss. p.a., reag. Ph. Eur., ≥99% (GC)
Sigma-Aldrich
Efavirenz, ≥98% (HPLC)
Supelco
1-Naphthol, PESTANAL®, analytical standard
Sigma-Aldrich
Trifluoperazine dihydrochloride, ≥99%, powder
Sigma-Aldrich
1-Naphthol, BioXtra, ≥99%
Propofol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Trifluoperazine hydrochloride, meets USP testing specifications
Finasteride, European Pharmacopoeia (EP) Reference Standard
Chenodeoxycholic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Chlorpropamide, analytical standard, ≥97%
USP
Theophylline, United States Pharmacopeia (USP) Reference Standard, certified reference material
Supelco
Theophylline melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Chlorpropamide, Pharmaceutical Secondary Standard; Certified Reference Material
Theophylline, European Pharmacopoeia (EP) Reference Standard
Propofol for peak identification, European Pharmacopoeia (EP) Reference Standard
Finasteride for peak identification, European Pharmacopoeia (EP) Reference Standard